AbbVie (ABBV) Long-Term Debt Issuances (2012 - 2026)

AbbVie (ABBV) has reported Long-Term Debt Issuances for 11 consecutive years, with $8.0 billion the latest figure, recorded in Q1 2026.

• On a quarterly basis, Long-Term Debt Issuances rose 100.08% year-over-year to $8.0 billion in Q1 2026; TTM through Jun 2026 was $8.0 billion, a 33.32% increase from a year earlier, with the FY2025 full-year figure at $4.0 billion, down 76.45% from the prior year.
• Long-Term Debt Issuances was $8.0 billion for Q1 2026 at AbbVie, up from $4.0 billion in the prior quarter.
• Over five years, Long-Term Debt Issuances peaked at $15.0 billion in Q1 2024 and troughed at $2.0 billion in Q1 2022.
• A 4-year average of $6.2 billion and a median of $4.0 billion in 2025 frame the typical range for Long-Term Debt Issuances.
• Across the five-year window, Long-Term Debt Issuances slumped 73.31% in 2025 and surged 100.08% in 2026, its largest moves.
• Over 4 years, Long-Term Debt Issuances stood at $2.0 billion in 2022, then changed by 0.0% to $2.0 billion in 2024, then surged by 99.7% to $4.0 billion in 2025, then surged by 100.08% to $8.0 billion in 2026.
• The last three Long-Term Debt Issuances figures came in at $8.0 billion (Q1 2026), $4.0 billion (Q1 2025), and $2.0 billion (Q4 2024), per Business Quant data.